{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:55:54Z","timestamp":1791780954326,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.lungcan.2011.01.020","type":"journal-article","created":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T14:15:10Z","timestamp":1298816110000},"source":"Crossref","is-referenced-by-count":10,"title":["Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial"],"prefix":"10.1016","clinical-trial-number":[{"clinical-trial-number":"nct00433563","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Hamid","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rovel","family":"Colaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lorigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Blackhall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Califano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Thatcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Faivre-Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2011.01.020_bib0005","first-page":"31","article-title":"Keynote address on biostatistics and data retrieval","volume":"4","author":"Zelen","year":"1973","journal-title":"Cancer Chemother Rep 3"},{"issue":"3","key":"10.1016\/j.lungcan.2011.01.020_bib0010","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.lungcan.2008.06.013","article-title":"Radiotherapy for small-cell lung cancer \u2013 where are we heading?","volume":"63","author":"Bayman","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3816\/CLC.2005.n.018","article-title":"Thoracic radiation therapy for limited-stage small-cell lung cancer. Unanswered questions","volume":"7","author":"Faivre-Finn","year":"2005","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0020","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/annonc\/mdj094","article-title":"Systematic review and meta-analysis of randomised, controlled trials of the timing of chest radiotherapy in patients with limited-stage, small-cell lung cancer","volume":"17","author":"De Ruysscher","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0025","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1200\/JCO.2004.01.178","article-title":"Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer","volume":"22","author":"Fried","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0030","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1634\/theoncologist.9-6-665","article-title":"A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer","volume":"9","author":"Huncharek","year":"2004","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1056\/NEJM199901283400403","article-title":"Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide","volume":"340","author":"Turrisi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0040","doi-asserted-by":"crossref","first-page":"7583","DOI":"10.1200\/jco.2008.26.15_suppl.7583","article-title":"Feasibility and toxicity report from a phase II study of accelerated twice-daily (BDRT) versus high dose once-daily thoracic radiotherapy (ODRT) with concurrent chemotherapy for limited stage small cell lung cancer (LS-SCLC)","volume":"26","author":"Faivre-Finn","year":"2008","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0045","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0050","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1200\/JCO.1995.13.7.1632","article-title":"Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group","volume":"13","author":"Bunn","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0055","unstructured":"http:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcaev3.pdf."},{"key":"10.1016\/j.lungcan.2011.01.020_bib0060","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1200\/JCO.2005.02.9793","article-title":"Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer","volume":"24","author":"De Ruysscher","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0065","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/jnci\/84.15.1201","article-title":"Severe myelosuppression resulting from concurrent administration of G-CSF and cytotoxic chemotherapy","volume":"84","author":"Meropol","year":"1992","journal-title":"JNCI"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0070","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1200\/JCO.2000.18.20.3558","article-title":"2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel","volume":"18","author":"Ozer","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0075","doi-asserted-by":"crossref","first-page":"18148","DOI":"10.1200\/jco.2007.25.18_suppl.18148","article-title":"Toxicity of G-CSF given for neutropenia during chest radiotherapy in limited-stage small cell lung cancer (SCLC)","volume":"25","author":"Karcznmarczyk","year":"2007","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"10.1016\/j.lungcan.2011.01.020_bib0080","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/JTO.0b013e3181d6e141","article-title":"Phase II trial of combined modality therapy with myeloid growth factors in patients with locally advanced non-small cell lung cancer","volume":"5","author":"Lilenbaum","year":"2010","journal-title":"J Thorac Oncol"},{"issue":"35","key":"10.1016\/j.lungcan.2011.01.020_bib0085","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1200\/JCO.2008.17.7840","article-title":"Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology","volume":"26","author":"Hanna","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2011.01.020_bib0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.bjc.6604480","article-title":"Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in SCLC","volume":"99","author":"Baka","year":"2008","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.lungcan.2011.01.020_bib0095","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1182\/blood-2008-12-164004","article-title":"The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease","volume":"114","author":"Hercus","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.lungcan.2011.01.020_bib0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2007-03-079681","article-title":"Haematopoietic cytokines","volume":"111","author":"Metcalf","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lungcan.2011.01.020_bib0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.lungcan.2011.01.020_bib0110","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.clon.2010.05.008","article-title":"Improving survival with thoracic radiotherapy in patients with small cell lung cancer. The CONVERT and the REST trials","volume":"22","author":"Faivre-Finn","year":"2010","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500211000894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500211000894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T23:47:48Z","timestamp":1592351268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500211000894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":22,"alternative-id":["S0169500211000894"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2011.01.020","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}